Elif TİGEN TÜKENMEZ, BUKET ERTÜRK ŞENGEL, Lütfiye MÜLAZIMOĞLU, VOLKAN KORTEN, Önder ERGÖNÜL, GÜLŞEN ALTINKANAT GELMEZ, Mahir ÖZGEN, Levent TÜRKERİ

Geniş spektrumlu beta laktamaz üreten Enterobacteriaceae taşıyıcılığının prostatın transrectal iğne biyopsisi sonuçlarına etkisi

Amaç: Bu çalışmada, transrektal prostat biyopsisi (TRPB) öncesi, hastalarda dışkıda geniş spektrumlu beta-laktamaz üreten Enterobacteriaceae (GSBL-ÜE) taşıyıcılığı oranları, risk faktörleri ve sonuçları gösterilmesi amaçlanmıştır. Hastalar ve Yöntem: Toplam 143 TRPB yapılan hasta çalışmaya alınmıştır. Bunların 33(%23)’ünde GSBL-ÜE taşıyıcılığı bulunmuştur. Ortalama hasta yaşı 62 ± 7,5 (43-81)dir. Bulgular: Tek değişkenli analizle son 2 ayda kinolon veya başka bir antibiyotik kullanımı, prostatit ve diabetes mellitus (DM) GSBL-ÜE taşıyıcılığı ile ilşkili bulunmuştur. Çok değişkenli analiz, son 2 ayda kinolon kullanımı (OR: 4,865; CI: 1,45-16,1), ve DM (OR: 4,04; CI: 1,64-10) varlığını önemli faktörler olarak göstermiştir. TRPB sonrası disüri (p

Anahtar Kelimeler:

Geniş spektrumlu beta-laktamaz, Transrektal prostat iğne biopsisi, Fekal taşıyıcılık, Enfeksiyon

-

Objective: This study aimed to address the prevalence, the risk factors and the results of fecal carriage of extended-spectrum betalactamase producing Enterobacteriaceae (ESBL-PE) in patients who had undergone transrectal needle biopsy of the prostate (TRNBP). Patients and Methods: A total of 143 patients who had undergone TRNBP were included. Of these, 33(23%) had fecal carriage of ESBL-PE. The mean age of the patients was 62 ± 7.5 (43-81) years. Results: A univariate analysis showed that quinolone or other antibiotic use within the last 2 months, prostatitis, and diabetes mellitus (DM) were significantly associated with the presence of ESBL-PE. A multivariate analysis showed that quinolone use within the past 2 months (OR: 4.865; CI: 1.45-16.1), and DM (OR: 4.04; CI: 1.64-10) were found to be significant. Development of dysuria (p

Keywords:

Extended-spectrum beta-lactamases, Transrectal needle biopsy of the prostate, Fecal carriage, Infection,

PDF

___

1. Pitout JDD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae-producing extended-spectrum beta- lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52–9. doi: 10.1093/jac/dki166.
2. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769- 75.
3. Woerther PL, Angebault C, Jacquier H, Hugede HC. Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 2011;53:677- 85. doi: 10.1093/cid/cir522.
4. Pallecchi L, Bartoloni A, Fiorelli C, et al. Rapid dissemination and diversity of CTX-M extended-spectrum betalactamase genes in commensal Escherichia coli from healthy children from lowresource settings of Latin America. Antimicrob Agents Chemother 2007;51:2720–5. doi:10.1128/AAC.00026-07.
5. Azap Kurt O, Arslan H, Karaman S, Togan T. Risk factors for fecal carriage of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in the community. Turk J Med Sci 2007; 37 : 31-8.
6. Thompson PM, Talbot RW, Packham DA, Dulake C. Transrectal biopsy of the prostate and bacteraemia. Br J Surg 1980; 67:127–8.
7. Lindstedt S, Lindström U, Ljunggren E, Wullt B, Grabe M. Singledose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol 2006;50:832-7.
8. Aus G,Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate: risk factors and antibiotic prophylaxis. Br J Urol 1996;77:851-5.
9. Valverde A, Grill F, Coque TM, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008;46:2796-9. doi: 10.1128/JCM.01008-08.
10. Ben Sallem R, Ben Slama K, Estepa V, et al. Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)- producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31:1511-6. doi: 10.1007/ s10096-011-1471-z
11. Vinué L, Sáenz Y, Martínez S, et al. Prevalence and diversity of extended spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009;15:954–6. doi: 10.1111/j.1469-0691.2009.02803.x.
12. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142-9. doi: 10.1093/jac/dkn293.
13. Ruddick F, Sanders P, Bicknell SG, Crofts P. Sepsis rates after ultrasound-guided prostate biopsy using a bowel preparation protocol in a community hospital. J Ultrasound Med 2011;30:213-6.
14. Silva N, Oliveira M, Bandeira AC, Brites C. Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil. Braz J Infect Dis 2006;10:191-3.
15. Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum betalactamase-producing escherichia coli in nonhospitalized patients. J Clin Microbiol 2004;42:1089-94.